Literature DB >> 2189157

Giant cell (temporal) arteritis.

G G Hunder1.   

Abstract

Giant cell arteritis is becoming recognized as one of the most common forms of vasculitis. However, its variable presentations and multiple features may make recognition difficult. Early diagnosis and treatment with cortico-steroids can prevent vascular occlusions. The challenge for the clinician is to use the lowest dose that suppresses the disease but also results in the fewest drug-related adverse effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189157

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  4 in total

1.  The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study.

Authors:  Christian Löffler; Johannes Hoffend; Urs Benck; Bernhard K Krämer; Raoul Bergner
Journal:  Clin Rheumatol       Date:  2017-05-15       Impact factor: 2.980

2.  Steroid management in giant cell arteritis.

Authors:  C C Chan; M Paine; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

3.  Preserved Visual Acuity in Anterior Ischemic Optic Neuropathy Secondary to Giant Cell (temporal) Arteritis.

Authors:  Aileen A Antonio-Santos; Sally J Murad-Kejbou; Rod Foroozan; Sunita Yedavally; David I Kaufman; Eric R Eggenberger
Journal:  J Vasc Interv Neurol       Date:  2016-01

4.  Temporal artery biopsy: impact on the clinical management of patients.

Authors:  M Sintler; A Garnham; A Mahmood; D Rittoo; H S Khaira; R K Vohra
Journal:  Indian J Surg       Date:  2008-05-21       Impact factor: 0.656

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.